Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Updates in melanoma from ASCO 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.06.18
Views: 762

Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands

Dr van Akkooi speaks with ecancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting about findings presented at a session he chaired on melanoma.

He highlights results from neoadjuvant and combination studies, including updates on staging and subsequent management of checkpoint blockade therapies.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

NCRI 2018


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation